Travere Therapeutics logo
Travere Therapeutics TVTX
$ 18.38 0.66%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Travere Therapeutics Operating Cash Flow 2011-2024 | TVTX

Annual Operating Cash Flow Travere Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-280 M -186 M -14.8 M -42.7 M -58.2 M -25 M 7.4 M -3.44 M -1.39 M - -17.6 M -2.74 M -689

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
7.4 M -280 M -52.1 M

Quarterly Operating Cash Flow Travere Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - -119 M - - - -81.1 M - -132 M - -55.3 M - 12.1 M - -26.5 M - -28.9 M -35.6 M -29.2 M - -53.7 M -39.6 M -20.5 M - -21.4 M -17.5 M -14.7 M - 8.26 M 2.06 M - - - - - - - - - - - - -9.81 M - - -6.79 M -4.58 M - -2.09 M -1.62 M -1.22 M - -67 -49 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
12.1 M -132 M -27.1 M